CPB has shown resilience through its strategic execution and focus on innovation while facing challenges related to a volatile consumer environment.
Lower inflation means less top-line growth from price hikes, and sales volume is under pressure as consumers are more selective.
Investing.com -- As signs emerge that demand for GLP-1 drugs is stronger than expected, many are fearing the worst for packaged-food companies, but Bernstein believes that some companies are likely to fare better than others as patients on these weight-loss drugs shift appetite in favor of more protein-based foods.